Compounds for the sustained reduction of body weight

Details for Australian Patent Application No. 2005205880 (hide)

Owner NeuroSearch A/S

Inventors Graff, Ole; Reess, Juergen; Priskorn, Morten; Pollentier, Stephane; Raschig, Andreas; Mikkelsen, Birgit Ohrt

Agent Davies Collison Cave

Pub. Number AU-B-2005205880

PCT Pub. Number WO2005/070427

Priority 04005816.6 11.03.04 EP; 04001282.5 22.01.04 EP

Filing date 11 January 2005

Wipo publication date 4 August 2005

Acceptance publication date 10 June 2010

International Classifications

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07H 17/08 (2006.01) Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

C12P 19/62 (2006.01) Preparation of compounds containing saccharide radicals

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/070427 Priority application(s): WO2005/070427

10 June 2010 Application Accepted

  Published as AU-B-2005205880

7 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205882-Pharmaceutical composition comprising a monoamine neurotransmitter reuptake inhibitor and an Nmethyl-D-aspartate (NMDA) receptors antagonist

2005205867-Transglutaminase mediated conjugation of peptides